Press Releases Orgenesis Inc.

Equities

ORGS

US68619K2042

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-03 pm EDT			5-day change	1st Jan Change
0.527 ^USD	-2.95%		+3.92%	+5.25%

Apr. 16	North American Morning Briefing : Powell Comments, -2-	DJ
Apr. 15	Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Orgenesis Provides Year End Business Update	Apr. 15	AQ
Orgenesis : Non-Reliance on Previously Issued Financial Report - Form 8-K	Apr. 15	PU
Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility	Apr. 10	AQ
Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference	Mar. 18	AQ
Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes	Mar. 13	AQ
Orgenesis Inc. Announces $2.3 Million Private Placement	Mar. 04	AQ
Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing	Feb. 29	AQ
Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic	Jan. 31	AQ
Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TM	Nov. 14	AQ
Orgenesis Provides Business Update for the Third Quarter of 2023	Nov. 13	AQ
Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering	Nov. 08	AQ
Orgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant Funding	Nov. 02	AQ
Orgenesis Announces Withdrawal of Proposed Public Offering	23-10-30	AQ
Orgenesis Announces Proposed Underwritten Public Offering	23-10-30	AQ
CGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United States	23-09-21	AQ
Cell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard Bauer, Joins Orgenesis Business, Octomera, to Drive Continued Expansion of POCare Facilities and Service Support	23-09-06	AQ
Orgenesis Provides Business Update for Second Quarter of 2023	23-08-11	AQ
Orgenesis Schedules Second Quarter 2023 Business Update Conference Call	23-08-10	AQ
Orgenesis Appoints Finance Veteran Elliot Maltz as its Chief Financial Officer	23-07-13	AQ
Orgenesis Announces Name Change of Morgenesis Business Unit to Octomera	23-07-11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Orgenesis Inc.

Equities

ORGS

US68619K2042

Press Releases

Filters